Cardiosense Launches Nationwide SEISMIC-HF II Study to Validate Its AI Algorithm for Non-Invasive Heart Failure Management
Cardiosense Noninvasively Measures Heart Failure’s Key Warning Signal
Results from Cardiosense’s SEISMIC-HF I Study of a Machine Learning Model to Non-Invasively Assess Cardiac Filling Pressure Presented as Late-Breaking Science at American Heart Association’s 2024 Scientific Sessions
Cardiosense Presents Interim Clinical Study Data for Machine Learning Algorithm to Aid in Heart Failure Management at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 Scientific Symposium
Cardiosense CardioTag Named “Best IoT Healthcare Wearable Device” in 8th Annual MedTech Breakthrough Awards Program
Cardiosense Begins Enrollment in Nationwide Heart Failure Study
Cardiosense lands $15M for AI to predict worsening heart disease from wearables
Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance AI Platform for Heart Disease
Dr. Omer Inan shares insight on academia and entrepreneurship – for example, how do they interact…and can a person pursue both?
Cardiosense receives FDA Breakthrough Device designation for algorithm to identify patients at risk of decompensated heart failure
